Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a rando...

por Kabul, Samaneh, Hood, Robert C., Duan, Ran, DeLozier, Amy M., Settles, Julie
Publicado 2016

Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort

por Andersen, Yuki M F, Nymand, Lea, DeLozier, Amy M, Burge, Russel, Edson-Heredia, Emily, Egeberg, Alexander
Publicado 2022

Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis

por Bacci, Elizabeth D., DeLozier, Amy M., Lin, Chen-Yen, Gaich, Carol L., Rooney, Terence, Hoffman, Richard, Wyrwich, Kathleen W.
Publicado 2017

Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7

por Thyssen, Jacob P., Buhl, Timo, Fernández-Peñas, Pablo, Kabashima, Kenji, Chen, Sherry, Lu, Na, DeLozier, Amy M., Casillas, Marta, Ständer, Sonja
Publicado 2021

Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer

por DeLozier, Amy M, Brown, Jacqueline, Natanegara, Fanni, Zhao, Luping, Cui, Zhanglin Lin, Able, Stephen L, Bowman, Lee, Treat, Joseph, Hess, Lisa M
Publicado 2014

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial

por Michaud, Kaleb, Pope, Janet E., Emery, Paul, Zhu, Baojin, Gaich, Carol L., DeLozier, Amy M., Zhang, Xiang, Dickson, Christina L., Smolen, Josef S.
Publicado 2019

Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation

por Bingham, Clifton O., Gaich, Carol L., DeLozier, Amy M., Engstrom, Kathryn D., Naegeli, April N., de Bono, Stephanie, Banerjee, Pixy, Taylor, Peter C.
Publicado 2019

Correction to: Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation

por Bingham, Clifton O., Gaich, Carol L., DeLozier, Amy M., Engstrom, Kathryn D., Naegeli, April N., de Bono, Stephanie, Banerjee, Pixy, Taylor, Peter C.
Publicado 2019

Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis

por Bacci, Elizabeth D., DeLozier, Amy M., Lin, Chen-Yen, Gaich, Carol L., Zhang, Xiang, Rooney, Terence, de Bono, Stephanie, Hoffman, Richard, Wyrwich, Kathleen W.
Publicado 2017

Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinic...

por Silverberg, Jonathan I., Simpson, Eric L., Wollenberg, Andreas, Bissonnette, Robert, Kabashima, Kenji, DeLozier, Amy M., Sun, Luna, Cardillo, Tracy, Nunes, Fabio P., Reich, Kristian
Publicado 2021

Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermati...

por Silverberg, Jonathan I., DeLozier, Amy, Sun, Luna, Thyssen, Jacob P., Kim, Brian, Yosipovitch, Gil, Nunes, Fabio P., Gugiu, P. Cristian, Doll, Helen A., Eichenfield, Lawrence F.
Publicado 2021

Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA

por Radawski, Christine, Genovese, Mark C., Hauber, Brett, Nowell, W. Benjamin, Hollis, Kelly, Gaich, Carol L., DeLozier, Amy M., Gavigan, Kelly, Reynolds, Maria, Cardoso, Anabela, Curtis, Jeffrey R.
Publicado 2019

Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis

por Emery, Paul, Blanco, Ricardo, Maldonado Cocco, Jose, Chen, Ying-Chou, Gaich, Carol L, DeLozier, Amy M, de Bono, Stephanie, Liu, Jiajun, Rooney, Terence, Chang, Cecile Hsiao-Chun, Dougados, Maxime
Publicado 2017

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis

por Simpson, Eric L., Bissonnette, Robert, Paller, Amy S., King, Brett, Silverberg, Jonathan I., Reich, Kristian, Thyssen, Jacob P., Doll, Helen, Sun, Luna, DeLozier, Amy M., Nunes, Fabio P., Eichenfield, Lawrence F.
Publicado 2022

Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)

por Smolen, Josef S, Kremer, Joel M, Gaich, Carol L, DeLozier, Amy M, Schlichting, Douglas E, Xie, Li, Stoykov, Ivaylo, Rooney, Terence, Bird, Paul, Sánchez Bursón, Juan Miguel, Genovese, Mark C, Combe, Bernard
Publicado 2017

Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis

por Newton, Louise, DeLozier, Amy M., Griffiths, Philip C., Hill, Jennifer N., Hudgens, Stacie, Symonds, Tara, Gable, Jonathon C., Paik, Jim, Wyrwich, Kathleen W., Eichenfield, Lawrence F., Abetz-Webb, Linda, Silverberg, Jonathan I.
Publicado 2019

Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study

por Keystone, Edward C, Taylor, Peter C, Tanaka, Yoshiya, Gaich, Carol, DeLozier, Amy M, Dudek, Anna, Zamora, Jorge Velasco, Cobos, Jose Arturo Covarrubias, Rooney, Terence, de Bono, Stephanie, Arora, Vipin, Linetzky, Bruno, Weinblatt, Michael E
Publicado 2017

Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment

por Schiff, Michael, Takeuchi, Tsutomu, Fleischmann, Roy, Gaich, Carol L., DeLozier, Amy M., Schlichting, Douglas, Kuo, Wen-Ling, Won, Ji-Eon, Carmack, Tara, Rooney, Terence, Durez, Patrick, Shaikh, Saeed, Hidalgo, Rodolfo Pardo, van Vollenhoven, Ronald, Zerbini, Cristiano A. F.
Publicado 2017

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial

por Reich, Kristian, Kabashima, Kenji, Peris, Ketty, Silverberg, Jonathan I., Eichenfield, Lawrence F., Bieber, Thomas, Kaszuba, Aleksandra, Kolodsick, Jill, Yang, Fan E., Gamalo, Margaret, Brinker, Dennis R., DeLozier, Amy M., Janes, Jonathan M., Nunes, Fabio P., Thyssen, Jacob P., Simpson, Eric L.
Publicado 2020